Whether antipsychotic treatment among patients with schizophrenia is associated with an increase or decrease in mortality risk is controversial. The effects of specific agents or routes on this association...
Although indoor smoking ban policies have helped reduce the prevalence of smoking, less is known about their association with personal smoking behavior changes. Data from the CARDIA study helped clarify...
The “conversion rate” from initial experimentation with cigarettes to daily smoking is a potentially important measure of smoking behavior. Using data from the Global Health Data Exchange, the authors of a...
Although the use of noncigarette tobacco products has increased, it is not fully known whether it affects future use of traditional cigarettes. Findings from the Population Assessment of Tobacco and Health...
In a recent study, researchers examined whether patients who did not meet the USPSTF eligibility criteria for lung cancer screening would be recommended for screening based upon individualized risk.
Opioid and substance use disorders have reached epidemic levels in the United States. In a recent study, researchers explored the prevalence of visits due to opioid-related complications in US emergency...
Depressive symptoms and elevated C-reactive protein levels are common among individuals with schizophrenia, but little is known about the relationship between these factors. In a recent study, researchers...